Fumi Varyani

1.1k total citations · 1 hit paper
13 papers, 784 citations indexed

About

Fumi Varyani is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Fumi Varyani has authored 13 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Surgery and 3 papers in Genetics. Recurrent topics in Fumi Varyani's work include Liver Disease Diagnosis and Treatment (3 papers), Liver Diseases and Immunity (3 papers) and Inflammatory Bowel Disease (3 papers). Fumi Varyani is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Liver Diseases and Immunity (3 papers) and Inflammatory Bowel Disease (3 papers). Fumi Varyani collaborates with scholars based in United Kingdom, Sweden and United States. Fumi Varyani's co-authors include Mark C. Petrie, John J.V. McMurray, Michael R. MacDonald, Jan Östergren, Eric L. Michelson, Marc A. Pfeffer, Karl Swedberg, Salim Yusuf, James B. Young and C. B. Granger and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Frontiers in Immunology.

In The Last Decade

Fumi Varyani

12 papers receiving 765 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

2008 503 citations Michael R. MacDonald, Mark C. Petrie et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fumi Varyani United Kingdom	9	469	333	156	107	87	13	784
A. Bionda Italy	11	74 0.2×	52 0.2×	128 0.8×	41 0.4×	191 2.2×	19	521
Christelle Maurey France	12	74 0.2×	75 0.2×	96 0.6×	92 0.9×	71 0.8×	41	548
Jeanie Kincer United States	7	54 0.1×	79 0.2×	120 0.8×	68 0.6×	47 0.5×	7	441
Joost C. M. Meijers Netherlands	7	61 0.1×	116 0.3×	39 0.3×	38 0.4×	107 1.2×	8	442
Yoshinobu Fuke Japan	13	34 0.1×	54 0.2×	46 0.3×	102 1.0×	75 0.9×	39	498
Kuang‐Chun Hu Taiwan	13	48 0.1×	42 0.1×	147 0.9×	28 0.3×	89 1.0×	33	389
S. Bousnina Tunisia	10	32 0.1×	198 0.6×	193 1.2×	142 1.3×	65 0.7×	68	570
Teemu Honkanen Finland	13	90 0.2×	85 0.3×	172 1.1×	94 0.9×	98 1.1×	19	622
C. D’Ambrosio Italy	12	119 0.3×	43 0.1×	96 0.6×	12 0.1×	139 1.6×	28	429
Joke van der Linden Netherlands	13	30 0.1×	32 0.1×	126 0.8×	159 1.5×	25 0.3×	22	569

Countries citing papers authored by Fumi Varyani

Since Specialization

Citations

This map shows the geographic impact of Fumi Varyani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumi Varyani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumi Varyani more than expected).

Fields of papers citing papers by Fumi Varyani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumi Varyani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumi Varyani. The network helps show where Fumi Varyani may publish in the future.

Co-authorship network of co-authors of Fumi Varyani

This figure shows the co-authorship network connecting the top 25 collaborators of Fumi Varyani. A scholar is included among the top collaborators of Fumi Varyani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumi Varyani. Fumi Varyani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Coupland, Ben, et al.. (2022). Improving 30-day mortality after PEG tube placement in England from 2007 to 2019: a retrospective national cohort analysis of 87,862 patients. Gastrointestinal Endoscopy. 96(6). 943–953.e11. 4 indexed citations

Varyani, Fumi, Stephan Löser, Kara J. Filbey, et al.. (2022). The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF). Mucosal Immunology. 15(6). 1243–1256. 23 indexed citations

Varyani, Fumi, et al.. (2019). Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data. SHILAP Revista de lepidopterología.

Varyani, Fumi & Sunil Samuel. (2019). “Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?”. Best Practice & Research Clinical Gastroenterology. 38-39. 101621–101621. 19 indexed citations

Filbey, Kara J., Fumi Varyani, Yvonne Harcus, et al.. (2019). Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite. Frontiers in Immunology. 10. 2375–2375. 22 indexed citations

Varyani, Fumi, et al.. (2019). <p>Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data</p>. Drug Design Development and Therapy. Volume 13. 4091–4105. 20 indexed citations

Smith, Katherine A., Stephan Löser, Fumi Varyani, et al.. (2018). Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion. eLife. 7. 38 indexed citations

Varyani, Fumi, John O. Fleming, & Rick M. Maizels. (2017). Helminths in the gastrointestinal tract as modulators of immunity and pathology. American Journal of Physiology-Gastrointestinal and Liver Physiology. 312(6). G537–G549. 55 indexed citations

Varyani, Fumi, Tim Card, Philip Kaye, Guruprasad P. Aithal, & Joe West. (2013). The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study. BMC Health Services Research. 13(1). 161–161. 7 indexed citations

10.

Varyani, Fumi, Joe West, & Tim Card. (2013). Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases?. Liver International. 33(3). 384–388. 5 indexed citations

11.

Varyani, Fumi, Joe West, & Tim Card. (2011). An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterology. 11(1). 95–95. 37 indexed citations

12.

MacDonald, Michael R., Mark C. Petrie, Fumi Varyani, et al.. (2008). Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal. 29(11). 1377–1385. 503 indexed citations breakdown →

13.

MacDonald, Michael R., Pardeep S. Jhund, Mark C. Petrie, et al.. (2008). Discordant Short- and Long-Term Outcomes Associated With Diabetes in Patients With Heart Failure: Importance of Age and Sex. Circulation Heart Failure. 1(4). 234–241. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact